PALLOCCA, MATTEO
 Distribuzione geografica
Continente #
NA - Nord America 429
EU - Europa 255
AS - Asia 92
AF - Africa 5
SA - Sud America 2
Totale 783
Nazione #
US - Stati Uniti d'America 427
IT - Italia 122
SG - Singapore 48
SE - Svezia 46
IE - Irlanda 38
IN - India 25
CN - Cina 11
DE - Germania 11
FI - Finlandia 9
ID - Indonesia 7
BG - Bulgaria 6
RO - Romania 6
TG - Togo 5
NL - Olanda 4
GB - Regno Unito 3
UA - Ucraina 3
AT - Austria 2
DK - Danimarca 2
CA - Canada 1
CL - Cile 1
EC - Ecuador 1
HR - Croazia 1
IR - Iran 1
LT - Lituania 1
MK - Macedonia 1
MX - Messico 1
Totale 783
Città #
Fairfield 79
Rome 56
Dublin 38
Singapore 35
Ashburn 32
Houston 31
Cambridge 27
Chandler 23
Seattle 21
Wilmington 20
Woodbridge 18
Princeton 14
Santa Clara 12
Ann Arbor 10
San Paolo di Civitate 10
Helsinki 9
San Diego 8
Des Moines 7
Jakarta 7
Boston 6
Dearborn 6
Lawrence 6
New York 6
Sofia 6
Andover 5
Lomé 5
Milan 5
Millbury 5
Plano 4
Beijing 3
Bremen 3
Cavallino 3
Naples 3
Ortona 3
Stockholm 3
Washington 3
Amsterdam 2
Carife 2
Castrocielo 2
Formia 2
Heidelberg 2
Mannheim 2
Minturno 2
Phoenix 2
Vienna 2
Avellino 1
Bologna 1
Bühl 1
Corridonia 1
Florence 1
Fremont 1
Guayaquil 1
Jacksonville 1
Kavadarci 1
Leawood 1
London 1
Los Angeles 1
Lu'an 1
Nanjing 1
Norwalk 1
Ottawa 1
Padova 1
Redwood City 1
Reggio Emilia 1
Santiago Metropolitan 1
Shanghai 1
Springfield 1
Verona 1
Xi'an 1
Zagreb 1
Zanjan 1
Totale 576
Nome #
B4GALT1 is a new candidate to maintain the stemness of lung cancer stem cells 117
Oncosuppressive miRNAs loaded in lipid nanoparticles potentiate targeted therapies in BRAF-mutant melanoma by inhibiting core escape pathways of resistance 89
Targeting a phospho-STAT3-miRNAs pathway improves vesicular hepatic steatosis in an in vitro and in vivo model 83
Conditionally reprogrammed cells (CRC) methodology does not allow the in vitro expansion of patient-derived primary and metastatic lung cancer cells 83
KEAP1-driven co-mutations in lung adenocarcinoma unresponsive to immunotherapy despite high tumor mutational burden 62
PTEN as a Prognostic/Predictive Biomarker in Cancer: An Unfulfilled Promise? 60
null 55
Efficacy of immunotherapy in lung cancer with co-occurring mutations in NOTCH and homologous repair genes 53
Organoids as a new model for improving regenerative medicine and cancer personalized therapy in renal diseases 48
Identification of a set of genes potentially responsible for resistance to ferroptosis in lung adenocarcinoma cancer stem cells 27
Che-1 sustains hypoxic response of colorectal cancer cells by affecting Hif-1α stabilization 25
Type I IFNs promote cancer cell stemness by triggering the epigenetic regulator KDM1B 23
Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription 21
null 21
null 20
Multicohort and cross-platform validation of a prognostic Wnt signature in colorectal cancer 19
null 17
CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells 14
Rachel score: a nomogram model for predicting the prognosis of lung neuroendocrine tumors 10
Machine learning endometrial cancer risk prediction model: integrating guidelines of European Society for Medical Oncology with the tumor immune framework 6
Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects 1
Targeting of mutant-p53 and MYC as a novel strategy to inhibit oncogenic SPAG5 activity in triple negative breast cancer 1
Totale 855
Categoria #
all - tutte 3.064
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020109 0 0 0 0 19 20 17 14 13 10 10 6
2020/202175 9 5 2 6 5 4 9 4 11 7 8 5
2021/2022142 2 3 6 9 19 12 5 12 8 9 41 16
2022/2023185 26 30 7 14 15 18 6 22 40 1 5 1
2023/2024156 6 17 6 17 9 23 6 9 3 18 21 21
2024/2025106 11 23 18 24 30 0 0 0 0 0 0 0
Totale 855